Trupanion, Inc. (NASDAQ:TRUP) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $45.33.

A number of equities research analysts have commented on the company. Northland Securities lifted their target price on Trupanion from $45.00 to $50.00 and gave the company a "market perform" rating in a research report on Thursday, October 31st. Piper Sandler upgraded Trupanion from a "neutral" rating to an "overweight" rating and set a $57.00 target price on the stock in a research report on Thursday, January 23rd. Finally, Stifel Nicolaus lifted their target price on Trupanion from $42.00 to $44.00 and gave the company a "hold" rating in a research report on Monday, January 6th.

Trupanion Trading Down 0.6 %

NASDAQ TRUP traded down $0.29 on Friday, reaching $47.04. 363,635 shares of the company were exchanged, compared to its average volume of 511,506. The business's fifty day moving average price is $49.84 and its 200 day moving average price is $47.10. The stock has a market capitalization of $1.99 billion, a P/E ratio of -147.00, a price-to-earnings-growth ratio of 8.27 and a beta of 1.60. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion has a fifty-two week low of $19.69 and a fifty-two week high of $57.90.

Insider Transactions at Trupanion

In other news, SVP Emily Dreyer sold 3,100 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the completion of the transaction, the senior vice president now directly owns 24,708 shares of the company's stock, valued at approximately $1,355,233.80. This represents a 11.15 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 622 shares of the stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the sale, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. This trade represents a 5.93 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 26,597 shares of company stock valued at $1,416,742. 5.50% of the stock is currently owned by corporate insiders.

Institutional Trading of Trupanion

A number of hedge funds and other institutional investors have recently modified their holdings of the business. FMR LLC boosted its stake in Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock valued at $49,213,000 after acquiring an additional 1,170,202 shares during the period. Barclays PLC raised its holdings in Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock worth $2,750,000 after purchasing an additional 47,262 shares in the last quarter. OmniStar Financial Group Inc. bought a new position in shares of Trupanion in the third quarter valued at $535,000. Centiva Capital LP bought a new position in shares of Trupanion in the third quarter valued at $595,000. Finally, FORA Capital LLC bought a new position in shares of Trupanion in the third quarter valued at $540,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.